192 related articles for article (PubMed ID: 38702814)
1. Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma.
Zhong YJ; Luo XM; Liu F; He ZQ; Yang SQ; Ma WJ; Wang JK; Dai YS; Zou RQ; Hu YF; Lv TR; Li FY; Hu HJ
J Transl Med; 2024 May; 22(1):422. PubMed ID: 38702814
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma.
Zhang M; Yang H; Wan L; Wang Z; Wang H; Ge C; Liu Y; Hao Y; Zhang D; Shi G; Gong Y; Ni Y; Wang C; Zhang Y; Xi J; Wang S; Shi L; Zhang L; Yue W; Pei X; Liu B; Yan X
J Hepatol; 2020 Nov; 73(5):1118-1130. PubMed ID: 32505533
[TBL] [Abstract][Full Text] [Related]
3. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
[TBL] [Abstract][Full Text] [Related]
4. PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.
Chen Z; Yu M; Yan J; Guo L; Zhang B; Liu S; Lei J; Zhang W; Zhou B; Gao J; Yang Z; Li X; Zhou J; Fan J; Ye Q; Li H; Xu Y; Xiao Y
Front Immunol; 2021; 12():647209. PubMed ID: 33841428
[TBL] [Abstract][Full Text] [Related]
5. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment.
Czekay RP; Higgins CE; Aydin HB; Samarakoon R; Subasi NB; Higgins SP; Lee H; Higgins PJ
Cells; 2024 May; 13(10):. PubMed ID: 38786020
[TBL] [Abstract][Full Text] [Related]
6. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
Wang Z; Du Y
Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma.
Toshida K; Itoh S; Harada N; Morinaga A; Yugawa K; Tomiyama T; Kosai-Fujimoto Y; Tomino T; Kurihara T; Nagao Y; Morita K; Oda Y; Yoshizumi T
Cancer Sci; 2023 Mar; 114(3):937-947. PubMed ID: 36369960
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
10. Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling.
Zhang D; Sun R; Di C; Li L; Zhao F; Han Y; Zhang W
Comput Biol Med; 2023 Nov; 166():107406. PubMed ID: 37729702
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptomics reveals the role of Macrophage-Naïve CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma.
Mo Z; Liu D; Chen Y; Luo J; Li W; Liu J; Yu L; Huang B; Zhang S
J Transl Med; 2022 Oct; 20(1):466. PubMed ID: 36221095
[TBL] [Abstract][Full Text] [Related]
12. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
13. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
Affo S; Nair A; Brundu F; Ravichandra A; Bhattacharjee S; Matsuda M; Chin L; Filliol A; Wen W; Song X; Decker A; Worley J; Caviglia JM; Yu L; Yin D; Saito Y; Savage T; Wells RG; Mack M; Zender L; Arpaia N; Remotti HE; Rabadan R; Sims P; Leblond AL; Weber A; Riener MO; Stockwell BR; Gaublomme J; Llovet JM; Kalluri R; Michalopoulos GK; Seki E; Sia D; Chen X; Califano A; Schwabe RF
Cancer Cell; 2021 Jun; 39(6):866-882.e11. PubMed ID: 33930309
[TBL] [Abstract][Full Text] [Related]
14. Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.
Wang S; Fan G; Li L; He Y; Lou N; Xie T; Dai L; Gao R; Yang M; Shi Y; Han X
Cancer Immunol Immunother; 2023 Jul; 72(7):2423-2442. PubMed ID: 37010552
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
[TBL] [Abstract][Full Text] [Related]
16. HS6ST1 overexpressed in cancer-associated fibroblast and inhibited cholangiocarcinoma progression.
Hu S; Xia C; Zou H; Ren W; Liu L; Wang L; Kang Q; He K; Wang T; Zhang X
Dig Liver Dis; 2023 Aug; 55(8):1114-1125. PubMed ID: 36586771
[TBL] [Abstract][Full Text] [Related]
17. Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma.
Li H; Qu L; Yang Y; Zhang H; Li X; Zhang X
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1592-1609.e9. PubMed ID: 35219893
[TBL] [Abstract][Full Text] [Related]
18. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis.
Kong J; Shen S; Zhang Z; Wang W
Cancer Biomark; 2020; 27(4):505-517. PubMed ID: 32116234
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration.
Lawal B; Kuo YC; Tang SL; Liu FC; Wu ATH; Lin HY; Huang HS
Cells; 2021 Oct; 10(11):. PubMed ID: 34831096
[TBL] [Abstract][Full Text] [Related]
20. Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer.
Huang T; Lu C; Zhang Y; Lin BY; Zhang ZJ; Zhu D; Wang L; Lu Y
Ann Med; 2023; 55(2):2250987. PubMed ID: 38375814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]